MARKET

HNSBF

HNSBF

Hansa Medical AB
EXMKT
3.300
NaN%
Closed 09:30 03/21 EDT
OPEN
--
PREV CLOSE
3.300
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.300
52 WEEK LOW
3.300
MARKET CAP
223.79M
P/E (TTM)
-2.8463
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HNSBF last week (0310-0314)?
Weekly Report · 5d ago
Weekly Report: what happened at HNSBF last week (0303-0307)?
Weekly Report · 03/10 11:59
Weekly Report: what happened at HNSBF last week (0224-0228)?
Weekly Report · 03/03 11:58
Weekly Report: what happened at HNSBF last week (0217-0221)?
Weekly Report · 02/24 11:58
Weekly Report: what happened at HNSBF last week (0210-0214)?
Weekly Report · 02/17 11:54
Weekly Report: what happened at HNSBF last week (0203-0207)?
Weekly Report · 02/10 11:47
Hansa Biopharma reports Q4 results
Seeking Alpha · 02/06 22:33
Hansa Biopharma sees 2025 growth through expanded IDEFIRIX adoption and new market reimbursements
Seeking Alpha · 02/06 18:13
More
About HNSBF
Hansa Biopharma AB, formerly Hansa Medical AB, is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations consist of research and development for drug discovery. The Company conducts several projects, among which primary are IdeS (Immunoglobulin G-degrading enzyme of Streptococcus pyogenes) and HBP-assay (Heparin Binding Protein-assay). IdeS’s goal is to enable transplantation that prevents antibody-mediated rejection. HBP-assay is a diagnostic method that aims to predict severe sepsis in patients with infectious disease symptoms. The Company’s patent portfolio consists of several patent families that geographically cover numerous jurisdictions, including the United States, Europe and Japan.

Webull offers Hansa Biopharma AB stock information, including EXMKT: HNSBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HNSBF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HNSBF stock methods without spending real money on the virtual paper trading platform.